CONCLUSIONS: Use of third line therapy for OAB has been reported to be less than 5%. This rate is higher at our institution, likely due to access to multiple FPMRS providers. The authors also use a care pathway that emphasizes early patient education on available options should they fail first and second line treatments. Even in a tertiary referral center it is likely that third line therapy is not being offered to many patients who would benefit from it. Our data demonstrate an opportunity for urologists to improve the quality of care and treatment success rates for OAB patients.
INTRODUCTION AND OBJECTIVES:
Female urethral diverticula (UD) may present with a variety of different symptoms including stress urinary incontinence (SUI). Surgical repair of SUI may be done concomitantly with urethral diverticulectomy. However, some surgeons may be reluctant to repair SUI at the time of urethral diverticulectomy due to the additional surgical time and potential morbidity of anti-incontinence surgery. We assessed surgical outcomes of the concomitant treatment of SUI at the time of transvaginal urethral diverticulectomy (TVUD) based on a selective approach.
METHODS: Following IRB approval, we identified patients with a UD and SUI who underwent TVUD between July 2004 and January 2016. SUI was documented before and after surgery using subjective and objective parameters. Autologous pubovaginal slings (APVS) were used selectively based on surgeon and patient preference. Postoperatively, the majority of patients were imaged prior to catheter removal with voiding-cystourethrogram.
RESULTS: A total of 61 patients underwent surgical treatment of urethral diverticula. There were 39 patients with UD and concomitant SUI. Mean age was 53 years (range 34-77). There were 22 Caucasians, and 17 African American patients. Mean follow-up was 16.2 months (range 1-72 months). There were 24 patients (62%) with SUI that underwent concomitant APVS. Of these 24 patients, 10 (42%) had prior SUI surgery. There was resolution of SUI in 20 of 24 patients (83%) who underwent a simultaneous APVS compared to 8 of 15 patients (53%) who underwent TVUD without APVS (2 patients lost to follow-up). One patient out of 22 developed de-novo SUI following TVUD. Surgery resulted in the improvement or resolution of the majority of preoperative symptoms including recurrent urinary tract infection (UTI) (82% vs. 15%), dyspareunia (64% vs. 8%), and urgency (56% vs. 13%) (preoperative vs. postoperative). Complications included two patients with prolonged urinary retention following APVS requiring sling lysis. There were 2 patients with a recurrent UD, one of which required repair 18 months post-operatively.
CONCLUSIONS: Female UD is often associated with SUI. Surgical reconstruction of UD often results in satisfactory control of urinary symptoms including SUI when both are treated concomitantly in those with bothersome symptoms. Treatment of SUI with APVS when undergoing TVUD is feasible with satisfactory outcomes. The decision whether or not to perform concomitant APVS at time of TVUD should be made on an individual basis after appropriate counseling. METHODS: This prospective randomised study was conducted between 2012 to 2015 in department of Urology King George's Medical University, Lucknow. Obstetric and gynaecologic fistula less than 4 cm were included. Those with complex or complicated fistula and fistula due to malignancy were excluded from this study. Patients were divided into two groups (group 1 and group 2) depending upon route of repair i.e. transvaginal or transabdominal respectively as per characteristics and location of fistula. These two groups were randomised into two subgroups (1A, 1B and 2A, 2B) based on with use and without use of interposition flap during fistula repair. Perioperative and post-operative parameters (blood loss, mean operating time, hospital stay, requirement of analgesics) were compared. All complications occurred in postoperative period till last follow eup were recorded and Clavien Dindo Classification was used to stratify them. RESULTS: Fifty-four patients underwent transvaginal repairgroup 1 (27 with Martius flap-group 1A and 27 with no Martius flap e group 1B). Sixty-six patients underwent transabdominal repair-group 2 (33 with interposition flap-group 2A and 33 with no flap e group 2B). Blood loss, mean operating time, hospital stay, requirement of analgesics were comparable between sub-group 1A versus 1B; and 2A versus 2B. Overall success rate of repair across all groups was 92.7% (115/124). Success rate was 88.9% in transvaginal repair with martius flap versus 92.6 % in transvaginal repair with no flap (P¼1.0) and it was 93.9 % in both subgroups of transabdominal repair (P¼1.0). Mean follow up period was 33.6 months (range 12-46). 9 out of 27 patients (33.3%) with Martius flap interposition had significantly reduced sensation on labia majora. Of these 9 patients, 5 cases reported numbness and 4 had pain compared to patients in group IB who did not report any altered sensation in labia. (P ¼ 0.001).
CONCLUSIONS: The success rates are similar in simple VVF repair irrespective of the use of interposition flaps. However, overall morbidity following repair with interposition flap is more when compared with repair without interposition flap either by transvaginal or by transabdominal route.
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